PHIBRO ANIMAL HEALTH ($PAHC) posted quarterly earnings results on Wednesday, August 27th. The company reported earnings of $0.57 per share, beating estimates of $0.53 by $0.04. The company also reported revenue of $378,700,000, beating estimates of $369,484,800 by $9,215,200.
You can see Quiver Quantitative's $PAHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PHIBRO ANIMAL HEALTH Hedge Fund Activity
We have seen 98 institutional investors add shares of PHIBRO ANIMAL HEALTH stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PZENA INVESTMENT MANAGEMENT LLC removed 723,830 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $18,486,618
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 680,383 shares (+inf%) to their portfolio in Q2 2025, for an estimated $17,376,981
- PARKWOOD LLC removed 481,528 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $10,285,438
- BLACKROCK, INC. removed 201,106 shares (-5.4%) from their portfolio in Q2 2025, for an estimated $5,136,247
- AMERICAN CENTURY COMPANIES INC removed 198,512 shares (-46.6%) from their portfolio in Q2 2025, for an estimated $5,069,996
- RANGER INVESTMENT MANAGEMENT, L.P. added 179,975 shares (+101.1%) to their portfolio in Q2 2025, for an estimated $4,596,561
- CITADEL ADVISORS LLC added 168,142 shares (+inf%) to their portfolio in Q2 2025, for an estimated $4,294,346
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PHIBRO ANIMAL HEALTH Price Targets
Multiple analysts have issued price targets for $PAHC recently. We have seen 2 analysts offer price targets for $PAHC in the last 6 months, with a median target of $30.5.
Here are some recent targets:
- Ekaterina Knyazkova from JP Morgan set a target price of $35.0 on 07/07/2025
- Erin Wright from Morgan Stanley set a target price of $26.0 on 06/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
